Feb 25 (Reuters) – The U.S. Food and Drug Administration said on Wednesday its advisory committee is set to meet on March 12 to discuss and make recommendations on the strain composition of influenza virus vaccines for use during the 2026-2027 influenza season.
(Reporting by Christy Santhosh in Bengaluru; Editing by Alan Barona)
Comments